Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899140-23-000514
Filing Date
2023-04-04
Accepted
2023-04-04 16:46:29
Documents
2
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5205
2 EXPLANATION OF RESPONSES ex991prokidney.htm EX-99.1 4614
  Complete submission text file 0000899140-23-000514.txt   11291
Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Issuer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 540 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address
Cowen Aaron (Reporting) CIK: 0001869640 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40560 | Film No.: 23798643